GALC Polyclonal antibody

GALC Polyclonal Antibody for WB,ELISA

Host / Isotype

Rabbit / IgG


human, mouse, rat





Cat no : 12887-1-AP


Galactocerebrosidase, galactosylceramidase, GALC, GALCERase

Tested Applications

Positive WB detected inA375 cells, HeLa cells, human placenta tissue, mouse brain tissue

Recommended dilution

Western Blot (WB)WB : 1:500-1:1000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Published Applications

IHCSee 1 publications below

Product Information

12887-1-AP targets GALC in WB, IHC,ELISA applications and shows reactivity with human, mouse, rat samples.

Tested Reactivity human, mouse, rat
Cited Reactivityhuman
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen GALC fusion protein Ag3915
Full Name galactosylceramidase
Calculated molecular weight 668 aa, 76 kDa
Observed molecular weight 50 kDa
GenBank accession numberBC036518
Gene symbol GALC
Gene ID (NCBI) 2581
Conjugate Unconjugated
Form Liquid
Purification Method Antigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

Galactosylceramidase (Galc) is a lysosomal enzyme involved in the catabolism of galactosylceramide, a major lipid in myelin, kidney, and epithelial cells of the small intestine and colon. The normal GALC mRNA encodes the 80 kDa precursor, which is processed into 50 and 30 kDa subunits. Mutation of GALC gene will lead to Krabbe disease (globoid cell leukodystrophy), an autosomal recessive neurodegenerative disorder that affects both the central and peripheral nervous system due to an enzymatic defect of galactocerebrosidase.


Product Specific Protocols
WB protocol for GALC antibody 12887-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols




A specific activity-based probe to monitor family GH59 galactosylceramidase - the enzyme deficient in Krabbe disease.

Authors - André Ra Marques